Real-time SEC alerts Start Free →
Profitelligence
Becton, Dickinson and Company
BDX HIGH Impact

Becton, Dickinson and Company

Dr. Michael Garrison to Retire from BD

| 8-K |Healthcare

Summary

On July 19, 2026, Dr. Michael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments at Becton, Dickinson and Company (BD), announced his intention to retire effective October 2, 2026. Dr. Garrison will remain in his role through the end of the fiscal year to ensure a smooth transition. A comprehensive search is underway to identify the next President of the Medical Essentials segment. Additionally, the BioPharma Systems segment will report directly to Thomas E. Polen, Chairman, CEO, and President of BD, streamlining the company's operating model.

Profitelligence Profitelligence Alerts

Get alerts for BDX

Be first to know when Becton, Dickinson and Company files with the SEC.

Set Up Alerts →

Filing Categories

CEO Resignation Key Executive Departure New CEO Appointed Key Executive Appointment Regulatory Investigation

Advertisement

About Becton, Dickinson and Company

Becton, Dickinson and Company, commonly known as BD, is a prominent American multinational corporation engaged in the development and manufacture of a diverse range of medical devices, instrument systems, and reagents. A key player in the healthcare industry, BD focuses on improving medical discovery, diagnostics, and the delivery of care. BD's products are instrumental in supporting healthcare professionals worldwide in enhancing patient safety and reducing the risks associated with healthcare workers. The company operates across three main segments: BD Medical, BD Life Sciences, and BD Interventional, impacting various sectors such as pharmaceuticals, hospital healthcare systems, and clinical laboratories. With a strong commitment to innovation and quality, Becton, Dickinson and Company contributes significantly to advancements in patient care, operating efficiency in medical settings, and is noted for its commitment to addressing healthcare challenges on a global scale. Headquartered in Franklin Lakes, New Jersey, BD maintains a robust presence across numerous countries, underpinning its influential role in the evolution and improvement of global healthcare infrastructure.

Exchange: NYSE Industry: Medical Instruments & Supplies Company Website →

Official SEC Documents

BDX
BDX Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement